Mia Hovell

Natural Sciences graduate with experience in expanded access programs and pharmaceutical commercial teams. Passionate about medical communications, healthcare policy, and patient advocacy. Proven track record in stakeholder collaboration, client management and driving project timelines in fast-paced pharmaceutical environments to improve global patient access.

EXPANDED ACCESS PROGRAM MANAGEMENT ASSOCIATE, September 2025- Current

• Management of over 15 expanded access, post-trial access and named-patient sales programs with 6 different pharmaceutical/biotechnology clients focusing on oncology and rare disease.
• Key strategic projects across regulatory, supply chain, finance, business development, quality, digital and medical teams.
• Day-to-day point of contact for clients, managing queries, weekly meetings, and translating complex requests into internal actions for strategic priorities.
• Key skills developed: stakeholder management across cross-functional teams, timeline tracking, prioritisation across competing demands, budget forecasting, risk identification and issue escalation, process improvement and workflow optimisation.

IMMUNOCORE COMMERCIAL PLACEMENT, September 2023- September 2024

• Strong industry knowledge through close collaboration with market access, sales, medical, compliance, and field teams.
• Marketing and launch strategies including omnichannel implementation and patient support programme initiatives.
• Planning and coordination of 2 product country launch events and 2 European sales meetings.
• Creation, review, and approval of marketing materials for field teams and congresses.
• Field insight through 2 field visits, strengthening understanding of HCP engagement and market dynamics.
• Review and updates to internal product and disease awareness playbooks for company-wide use.

TAKEDA PHARMACEUTICAL COMPANY, September 2022

• Gained exposure to marketing, sales, medical affairs, market access, and external affairs functions.
• Participated in a cross-functional tactical planning meeting for a new post-transplant infection therapy.

BSc(Hons) Natural Sciences (Biochemistry with Pharmacology) with a professional placement year at the University of Bath.

• Graduated in 2025 with a 2:1.

Relevant modules: Recent advances in drug discovery, Marketing, The molecular biology and treatment of cancer, Cell biology, Biochemistry, Molecular and cellular neuroscience, Advanced developmental genetics, Issues in science education.

Parkstone Grammar School, Poole 2014-2021

A-levels: Chemistry A*, Psychology A*, Biology A*

GCSEs: 8 Grade 9s, 2 Grade 8s including Mathematics (9) English Language (8)

• ABPI Code of Practice knowledge
• Advanced Microsoft Office skills (Word, PowerPoint, Excel, Teams)
• Veeva PromoMats (digital asset management, MLR submission and approval workflows)